Expanding the number of validated iPSC-derived cardiomyocytes for safety pharmacology studies
2021 ◽
Vol 111
◽
pp. 107030
Keyword(s):
2014 ◽
Vol 69
(1)
◽
pp. 135-140
◽
1997 ◽
Vol 16
(1)
◽
pp. 21-22
◽
2007 ◽
Vol 56
(2)
◽
pp. e24
Keyword(s):
2019 ◽
Vol 96
◽
pp. 15-26
◽
Keyword(s):
2010 ◽
Vol 62
(2)
◽
pp. e27
Keyword(s):